TY  - CHAP
AU  - Emmanuel Drouet
ED  - Emmanuel Drouet
Y1  - 2021-10-28
PY  - 2021
T1  - Epstein-Barr Virus: Should We Still Invest in Vaccines or Focus on Predictive Tests?
N2  - Epstein-Barr virus (EBV) is a fascinating microorganism, as a “double-facetted” viral agent. After primary infection, it can persist throughout a person’s lifetime in a latent form, from which it can reactivate following specific stimuli (i.e., immunodepression). Unlike other herpesviruses, EBV reactivates a countless number of times with such a high replication rate that it is unable to be controlled by conventional anti-herpesvirus drugs. Moreover, for various reasons, no vaccine is currently available in the market. This book presents a comprehensive overview of EBV, including information on its potential for oncogenic activity, its various isolates, and possible vaccine candidates.
BT  - Epstein-Barr Virus
SP  - Ch. 6
UR  - https://doi.org/10.5772/intechopen.101094
DO  - 10.5772/intechopen.101094
SN  - 978-1-83968-490-6
PB  - IntechOpen
CY  - Rijeka
Y2  - 2024-04-19
ER  -